August 20, 2014 12:05 PM ET

Healthcare Equipment and Supplies

Company Overview of PharmaJet, Inc.

Company Overview

PharmaJet, Inc., a medical device company, develops and markets needle-free injection technology to deliver drugs and vaccines to intramuscular, subcutaneous, and intradermal tissue depths. It provides PharmaJet needle-free system that delivers liquid medications at high speed creating a ‘liquid jet’ to penetrate the skin and deliver the medicine through the skin. The company serves individual patients and public health needs in the United States and internationally. PharmaJet, Inc. was incorporated in 2005 and is based in Golden, Colorado with locations in Denver, Colorado; San Francisco, California; and Baltimore, Maryland.

400 Corporate Circle

Suite N

Golden, CO 80401

United States

Founded in 2005





Key Executives for PharmaJet, Inc.

President and Chief Operating officer
Age: 57
Chief Financial Officer and Vice President
Design & Production Chief
Global Head of Applications Development
Compensation as of Fiscal Year 2014.

PharmaJet, Inc. Key Developments

FDA Approves Use of AFLURIA Influenza Vaccine with PharmaJet, Inc.'s Needle-Free Injector

PharmaJet, Inc. announced the U.S. Food and Drug Administration (FDA) has approved the PharmaJet Stratis(R) 0.5mL Needle-Free Jet Injector for delivery of AFLURIA in individuals aged 18 to 64 years. This is the first needle-free delivery system approved by the FDA for the administration of an inactivated influenza vaccine. Needlestick injuries pose a serious risk to healthcare workers who administer vaccinations and manage sharps disposal. Among retail pharmacists alone, a National Institute for Occupational Safety and Health study reveals that the incidence of needlestick injury is up to 3.62 per 100,000 vaccinations administered. PharmaJet's needle-free injection technology eliminates needlestick injuries, needle re-use and potential cross contamination, as well as reduces sharps waste management and disposal costs.

PharmaJet, Inc. Enters into Strategic Collaboration with CSL Ltd. for Needle-Free Delivery of Influenza Vaccines

PharmaJet Inc. has entered into a collaboration with CSL Limited to enable Afluria(R) influenza vaccine to be delivered with the PharmaJet Stratis(R) needle-free jet injector, as soon as the 2013-2014 flu season. Adding PharmaJet jet injectors to the Afluria(R) label will expand the delivery options for flu vaccine administration, thereby helping to broaden immunization coverage. The Centers for Disease Control and Prevention recommends an annual flu vaccination for all US citizens over 6 months old. Flu shots have proven to reduce illness, absenteeism and flu-related medical expenses. For many people, the fear of needles is enough to deter receiving a seasonal flu shot, despite the risk of contracting and spreading the illness. Afluria(R), is a non-adjuvanted seasonal influenza vaccine sold in two different formulations: thimerosal-free, pre-filled syringes, and in multi-dose vials. CSL Biotherapies and PharmaJet are working to include jet injectors as a method of administration on the Afluria(R) label in time for the 2013-2014 flu season. PharmaJet's collaboration with CSL involves conducting a Phase IV clinical study to demonstrate the immunogenicity and safety of Afluria(R), presented in multi-dose vials, when administered with PharmaJet Stratis(R) needle-free device. Pending favorable clinical results, CSL will submit a Supplement to Afluria(R)'s BLA to include the option of needle-free jet injection on the Afluria(R) labeling.

Similar Private Companies By Industry

Company Name Region
Ikonisys, Inc. United States
Bespoke Innovations, Inc. United States
Claro Scientific, LLC United States
Isensix, Inc. United States
Luther Needlesafe Products Inc. United States

Recent Private Companies Transactions

Private Placement
May 19, 2014

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PharmaJet, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at